Introduction
Medulloblastoma is a malignant brain tumor that usually develops in the cerebellum, the part of the brain responsible for balance, coordination and movement. It is the most common cancerous brain tumor in children, although it can also occur in adults. Because medulloblastoma can grow quickly and may spread through cerebrospinal fluid (CSF), early diagnosis and specialist treatment are important.
Overview
Medulloblastoma is a type of malignant central nervous system (CNS) tumor that most commonly begins in the lower back portion of the brain, particularly the cerebellum.
The cerebellum helps control:
- Balance
- Walking
- Coordination
- Fine motor movements
- Posture
Medulloblastoma develops when certain cells acquire genetic changes that cause them to grow and multiply abnormally. The tumor can grow rapidly and may block the normal circulation of cerebrospinal fluid, causing increased pressure inside the skull, known as hydrocephalus.
Unlike many cancers, medulloblastoma generally does not spread to distant organs. However, it can spread through the cerebrospinal fluid to other areas of the brain and spinal cord.
Develop Medulloblastoma
Medulloblastoma can occur at any age, but it is much more common in children.
It is particularly important in pediatric oncology because it represents one of the major malignant brain tumors affecting children. Adults can also develop medulloblastoma, although adult cases are less common.
The symptoms and treatment approach can differ according to:
- Age
- Tumor location
- Molecular group
- Tumor spread
- Amount of tumor remaining after surgery
- Overall health
Symptoms
Symptoms depend on the tumor’s location, size and effect on the flow of cerebrospinal fluid.
Common symptoms include:
1. Morning Headache
Headaches may be worse in the morning because increased pressure inside the skull can occur when the person is lying down for several hours.
Persistent or progressively worsening headaches should be evaluated by a healthcare professional.
2. Nausea and Vomiting
Repeated nausea or vomiting, particularly when associated with headaches, may occur because of increased intracranial pressure.
3. Balance Problems
Because the cerebellum controls balance and coordination, a person may develop:
- Unsteady walking
- Difficulty maintaining balance
- Clumsiness
- Problems with coordination
4. Dizziness
Some people may experience dizziness or difficulty coordinating movements.
5. Vision Problems
Possible visual symptoms include:
- Double vision
- Blurred vision
- Abnormal eye movements
6. Tiredness or Sleepiness
Increased pressure within the skull may cause unusual tiredness or sleepiness.
7. Seizures
Seizures can occur in some people with brain tumors, although they are not present in every person with medulloblastoma.
Risk Factors for Medulloblastoma
Most people who develop medulloblastoma do not have an identifiable risk factor.
Age
Medulloblastoma occurs most frequently in children, although adults can also be affected.
Genetic Syndromes
Rare inherited conditions associated with an increased risk include:
- Gorlin syndrome
- Li-Fraumeni syndrome
- Turcot syndrome
- Fanconi anemia
- Rubinstein-Taybi syndrome
These conditions account for only a small proportion of cases.
Lifestyle Factors
Unlike some other cancers, there are no established lifestyle or environmental risk factors that explain most cases of medulloblastoma
Types of Medulloblastoma
Modern classification places considerable importance on the molecular characteristics of the tumor.
The four major molecular groups are:
1. WNT-Activated Medulloblastoma
WNT-activated tumors are associated with specific changes in the WNT signaling pathway.
They are often seen in older children and teenagers and generally have a more favorable prognosis compared with some other molecular groups.
2. SHH-Activated Medulloblastoma
SHH stands for Sonic Hedgehog.
SHH-activated medulloblastoma can occur in infants, children and adults. Its behavior can vary depending on additional genetic characteristics, including TP53 status.
3. Group 3
Group 3 tumors are non-WNT/non-SHH tumors and can occur particularly in younger children.
Some Group 3 tumors have a higher tendency to spread and may require intensive treatment.
4. Group 4
Group 4 is one of the most common molecular groups.
It can occur in children and adults, and its behavior can vary considerably between patients.
Important: Molecular classification is more than simply naming the tumor. It can help doctors understand tumor behavior, estimate risk and plan treatment.
Causes of Medulloblastoma
The exact cause of most medulloblastomas is not known.Cancer develops when genetic changes affect the normal controls that regulate cell growth, division and cell death.In medulloblastoma, changes involving important developmental and cell-signaling pathways can contribute to abnormal tumor growth.Most cases are not inherited. However, a small proportion may be associated with inherited genetic conditions.
Diagnosis
Diagnosis generally involves a combination of neurological examination, brain imaging, surgery/tissue examination and additional tests to determine whether the tumor has spread.
1. Neurological Examination
A doctor may assess:
- Balance
- Coordination
- Walking
- Reflexes
- Vision
- Eye movements
- Hearing
- Muscle strength
These findings can provide clues about which part of the nervous system may be affected.
2. MRI Brain
Magnetic Resonance Imaging (MRI) is one of the most important imaging tests for suspected medulloblastoma.
MRI can help determine:
- Tumor location
- Tumor size
- Relationship to surrounding brain structures
- Hydrocephalus
- Possible spread
A spinal MRI may also be performed to look for tumor spread along the brain and spinal cord.
3. CT Scan
A CT scan may be used in certain situations, particularly when rapid imaging is needed or MRI is not immediately available.
However, MRI generally provides more detailed information about the brain and spinal cord.
4. Surgery and Tissue Examination
When medically appropriate, surgery is usually performed both to obtain tissue for diagnosis and to remove as much tumor as can be safely removed.
The tissue is examined by specialists called neuropathologists.
Laboratory testing helps confirm the diagnosis and determine the tumor’s characteristics.
5. Cerebrospinal Fluid Examination
A lumbar puncture (spinal tap) may be performed to examine cerebrospinal fluid for tumor cells.
This test is generally performed only when it is considered safe, particularly after management of increased intracranial pressure or after surgery.
6. Molecular and Genetic Testing
Modern diagnosis increasingly includes molecular testing.
Testing may help identify:
- WNT-activated tumors
- SHH-activated tumors
- Group 3
- Group 4
- Relevant genetic alterations
Molecular information can contribute to risk stratification and treatment planning.
Treatment
Treatment should be planned by a specialized multidisciplinary medical team. The choice of treatment depends on the patient’s age, tumor type, molecular findings, tumor spread, overall health, and how much of the tumor can be safely removed.
- Surgery – To remove as much of the tumor as safely possible and obtain tissue for diagnosis and molecular testing.
- Radiation Therapy – May be used after surgery to treat remaining tumor cells and reduce the risk of recurrence, depending on age and risk group.
- Chemotherapy – May be given before or after radiation to destroy cancer cells and reduce the chance of the tumor returning.
- Clinical Trials – New treatments and treatment combinations may be available through clinical trials, particularly for high-risk or recurrent medulloblastoma.
Conclusion
Medulloblastoma is a malignant, fast-growing grade 4 brain tumor that most commonly develops in the cerebellum and is particularly important in children. It can cause headaches, vomiting, balance problems, coordination difficulties, visual changes and other neurological symptoms.Diagnosis commonly involves neurological examination, MRI of the brain and spine, surgical tissue examination, cerebrospinal fluid testing when appropriate, and molecular testing.
Treatment generally involves surgery followed by radiation therapy, chemotherapy or a combination of these treatments, depending on the patient’s age, molecular group, tumor spread and risk classification.
Disclaimer
This article is provided for educational and general health-information purposes only. It should not be considered a substitute for professional medical advice, diagnosis or treatment. Laboratory results must be interpreted in the appropriate clinical context. Consult a qualified healthcare professional for individual medical concerns.
Frequently Asked Questions
Is medulloblastoma a cancer?
Yes. Medulloblastoma is a malignant central nervous system tumor and is classified as a WHO grade 4 tumor.
Where does medulloblastoma occur?
It most commonly develops in the cerebellum, located in the lower back portion of the brain.
Can medulloblastoma spread?
Yes. It can spread through cerebrospinal fluid to other areas of the brain and spinal cord.
Written by Jambir Sk Certified Medical Laboratory Technologist
Disclaimer: This content is for educational purposes only and should not be consideredas medical advice. Always consult a qualified doctor.We do not provide professional medical advice, diagnosis, or treatment.All health-related content is based on research, knowledge, and general awareness.Always consult a licensed healthcare provider for any medical concerns.HealthSeba.com will not be responsible for any loss, harm, or damage caused by the use of information available on this site.
References & Sources
Medical & Educational Sources
Related Posts
Genetics Of Diabetes
Introduction Genetics of diabetes shows how hereditary factors influence the…
Histopathology Staining
Introduction Microscopic tissue evaluation depends on color contrast to identify…